🤖 GLOBAL HEALTH OPTIMIZATION AGENT v3.0

🔬 Current Disease Focus:

Task Progress: 0%

👥 Active Problem Solvers

🌍 Experts collaborating globally

⚡ Current Task Assignment

🧬 Genetic Analysis

🔄 Matching experts to specific tasks

📊 Resource Allocation by Research Phase:

📚 Data Analysis

🧪 Experimental Design

🔬 Clinical Trials

💊 Treatment Development

Trial Search

Current Search Criteria:

Intervention: Biological Sampling

Found 0 matching trials

GWAS in NMDAR Encephalitis

N/A

Autoimmune encephalitis are characterized by the subacute development of me...

Status

Unknown

Location

Centre de référence des syndromes neurologiques paranéoplasiques et encéphalites auto-immunes

Start Date

2020-12-15

Trial ID

NCT05225883

Treatments Being Tested

GWAS

Medical Comorbidities in Bipolar Disorder

N/A

Bipolar Disorder (BD) is a common, heritable, chronic, and recurrent disord...

Status

Recruiting

Location

France

Start Date

2024-10-11

Trial ID

NCT06872398

Treatments Being Tested

Blood and saliva sampling

DNA QUANTIFICATION TECHNIQUE AS A INTERPRETATION TOOL IN MITOCHONDRIAL DISEASES

2622/5000 Mitochondrial diseases (MM) are the most common metabolic disease...

Status

Completed

Location

CHU de Nice

Start Date

2018-02-02

Trial ID

NCT03216252

Treatments Being Tested

samples

Real-time Monitoring of Cortisol - Comparison of Cortisol Levels in Four Biological Fluids

N/A

Cortisol is an essential for life hormone secreted in a pulsatile pattern o...

Status

Unknown

Location

Centre Hospitalier Universitaire Vaudois (CHUV)

Start Date

2021-09-01

Trial ID

NCT06008184

Treatments Being Tested

24 hours sampling of 4 biological fluids (blood, ISF, sweat and saliva)24 hours sampling of ISF or sweat (after validating the correlation with blood)

Morphine Clearance and Glomerular Filtration in Sickle Cell Patients in Crisis in Intensive Care

Background: Sickle cell disease is a genetic disorder of haemoglobin (which...

Status

Recruiting

Location

CHRU de Tours

Start Date

2026-03-05

Trial ID

NCT07246265

Treatments Being Tested

Injection of iohexol for glomerular filtration rate (GFR) measurement

An Extension to Study MALARIA-055 PRI (NCT00866619) to Evaluate the Long-term Efficacy, Safety and Immunogenicity of GSK Biologicals' Candidate Malaria Vaccine in Infants and Children in Africa

PHASE3

The purpose of this study is to conduct long-term surveillance for efficacy...

Status

Completed

Location

GSK Investigational Site

Start Date

2014-09-18

Trial ID

NCT02207816

Treatments Being Tested

Blood sampling Malaria Vaccine 257049 (MALARIA-055 PRI)Meningococcal C Conjugate Vaccine (MALARIA-055 PRI)Cell-culture rabies vaccine (MALARIA-055 PRI)TritanrixHepB/Hib (MALARIA-055 PRI)Polio Sabin Oral Polio Vaccine (GSK) (MALARIA-055 PRI)

Genetic Study of Immunodeficiency: Search for New Genetic Causes for Primary Immunodeficiencies

N/A

Individuals with suspected primary immunodeficiency will be studied and the...

Status

Recruiting

Location

Division of Immunology

Start Date

2016-02

Trial ID

NCT02735824

Treatments Being Tested

Skin Biopsy Mouth Swab or Saliva Collection Blood Sampling

International Rare And Severe Psoriasis Expert Network

N/A

This registry is a prospective observational study in order to describe pri...

Status

Recruiting

Location

Klinikum der Universität München

Start Date

2021-09-22

Trial ID

NCT04359394

Treatments Being Tested

biological sampling Phenotypic description Photography

Follow-up of a National Cohort of Melanoma Resectable Stage II, Stage III or IV Patients or Unresectable Primary

N/A

Prevention of melanoma can be efficient but mortality remains unchanged and...

Status

Recruiting

Location

CHU d'Amiens

Start Date

2013-02

Trial ID

NCT02828202

Treatments Being Tested

Biological Tissular Quality of life

Characterization and Support of Neurodevelopmental Disorders Associated With Congenital Cardiac malfoRmations - Neonatal

N/A

Congenital heart defects (CHD), as the leading cause of birth defects, affe...

Status

Recruiting

Location

Nantes University Hospital

Start Date

2025-02-28

Trial ID

NCT06690151

Treatments Being Tested

Neurodevelopmental assessment (Bayley-IV)Biological sampling ELFE dietary questionnaire Post-Traumatic Stress Questionnaire IES-R (Impact of Event Scale - Revised)Data collection for the study (Cardiovascular, developemental, fetal, pregnancy, MRI)

Previous Next